J Korean Med Sci.  1999 Apr;14(2):153-158. 10.3346/jkms.1999.14.2.153.

Comparison of basophil histamine releasability between atopic and nonatopic thmatics

Affiliations
  • 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Medical Research Center, Korea.

Abstract

To compare the mediator releasability between atopic and nonatopic asthmatics, we measured basophil histamine releasability (BaHR) using a calcium-ionophore A23187 and anti-IgE in 137 subjects who were treated at Seoul National University Hospital. Subjects were categorized into atopic (group AA, n=77) or nonatopic asthmatics (group NA, n=32), or normal controls (group NC, n=28). Serum total IgE levels were determined and correlation with BaHR was assessed. Anti-IgE-induced maximal BaHR in groups AA, NA, and NC was 41.0+/-3.2, 23.1+/-4.5, and 16.8+/-3.8, respectively (mean+/-SE, %). Anti-IgE-induced BaHR in group AA was significantly higher than that in groups NA and NC (p<0.05). Calcium ionophore A23187-induced maximal BaHR was 43.1+/-2.8, 40.8+/-4.4, and 50.5+/-5.2, respectively (mean+/-SE, %), and there was no significant difference among the groups. Serum total IgE level correlated significantly with anti-IgE-induced maximal BaHR (r=0.281, p<0.01) but not with that induced by calcium ionophore A23187. In conclusion, IgE receptor-related BaHR is higher in atopic asthmatics than in nonatopic asthmatics, and this increased BaHR in atopics is significantly associated with increased serum total IgE level.

Keyword

Basophils; Histamine release; Asthma; Hypersensitivity, immediate

MeSH Terms

Asthma/immunology*
Basophils/immunology*
Basophils/drug effects
Calcimycin/pharmacology
Child
Comparative Study
Histamine Release/immunology*
Histamine Release/drug effects
Human
IgE/immunology*
IgE/blood
Ionophores/pharmacology
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr